文献速递肾血管病与高血压慢性肾脏病

α2A肾上腺素受体调控肾脏交感神经传递并预防高血压肾病

α2A-Adrenoceptors Modulate Renal Sympathetic Neurotransmission and Protect against Hypertensive Kidney Disease.
PubMed 文献 · J Am Soc Nephrol · 2020-02-21

本研究在单侧肾切除的野生型与α2A肾上腺素受体敲除小鼠中,通过输注血管紧张素II 28天诱导高血压肾病。结果发现敲除小鼠尿去甲肾上腺素排泄增加,收缩压较野生型高约40 mmHg,肾损伤更重;去肾交感神经可减轻上述效应,提示突触前α2A受体具有保护作用。

要点

  • α2A受体敲除加重AngII诱导的高血压和肾损伤。
  • 敲除小鼠收缩压较野生型高约40 mmHg。
  • 去肾交感神经可减轻敲除小鼠的高血压和肾损伤。

核心结论

  • 突触前抑制性α2A肾上腺素受体在肾素-血管紧张素系统激活的高血压肾病中起保护作用。

研究设计与样本

  • 单侧肾切除的野生型和α2A肾上腺素受体敲除小鼠,输注AngII 28天诱导高血压肾病。

主要发现

  • 基线时敲除与野生型小鼠尿NE排泄和血压无差异。
  • AngII处理期间敲除小鼠尿NE排泄显著高于野生型。
  • 敲除小鼠收缩压较野生型高约40 mmHg,肾损伤更重。
  • 离体肾中AngII增强的肾神经刺激在敲除小鼠引起更明显的NE释放和升压反应。
  • 去肾交感神经后敲除小鼠AngII介导的高血压减轻、肾功能改善。

临床怎么用

  • 支持交感神经抑制疗法作为高血压肾病治疗策略的概念。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Increased nerve activity causes hypertension and kidney disease. Recent studies suggest that renal denervation reduces BP in patients with hypertension. Renal NE release is regulated by prejunctional α2A-adrenoceptors on sympathetic nerves, and α2A-adrenoceptors act as autoreceptors by binding endogenous NE to inhibit its own release. However, the role of α2A-adrenoceptors in the pathogenesis of hypertensive kidney disease is unknown. METHODS: We investigated effects of α2A-adrenoceptor-regulated renal NE release on the development of angiotensin II-dependent hypertension and kidney disease. In uninephrectomized wild-type and α2A-adrenoceptor-knockout mice, we induced hypertensive kidney disease by infusing AngII for 28 days. RESULTS: Urinary NE excretion and BP did not differ between normotensive α2A-adrenoceptor-knockout mice and wild-type mice at baseline. However, NE excretion increased during AngII treatment, with the knockout mice displaying NE levels that were significantly higher than those of wild-type mice. Accordingly, the α2A-adrenoceptor-knockout mice exhibited a systolic BP increase, which was about 40 mm Hg higher than that found in wild-type mice, and more extensive kidney damage. In isolated kidneys, AngII-enhanced renal nerve stimulation induced NE release and pressor responses to a greater extent in kidneys from α2A-adrenoceptor-knockout mice. Activation of specific sodium transporters accompanied the exaggerated hypertensive BP response in α2A-adrenoceptor-deficient kidneys. These effects depend on renal nerves, as demonstrated by reduced severity of AngII-mediated hypertension and improved kidney function observed in α2A-adrenoceptor-knockout mice after renal denervation. CONCLUSIONS: Our findings reveal a protective role of prejunctional inhibitory α2A-adrenoceptors in pathophysiologic conditions with an activated renin-angiotensin system, such as hypertensive kidney disease, and support the concept of sympatholytic therapy as a treatment.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Hering L, Rahman M, Hoch H, et al. α2A-Adrenoceptors Modulate Renal Sympathetic Neurotransmission and Protect against Hypertensive Kidney Disease. J Am Soc Nephrol. 2020. PMID: 32086277. doi:10.1681/ASN.2019060599

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。